Cargando...
ADAMTS13 Test and/or PLASMIC Clinical Score in Management of Acquired Thrombotic Thrombocytopenic Purpura – A cost-effective analysis
BACKGROUND: ADAMTS13 test distinguishes thrombotic thrombocytopenic purpura (TTP) from other thrombotic microangiopathies (TMAs). PLASMIC score helps determine the pretest probability of ADAMTS13 deficiency. Due to inherent limitations of both tests, and potential adverse effects and cost of unneces...
Gardado en:
| Publicado en: | Transfusion |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5673545/ https://ncbi.nlm.nih.gov/pubmed/28646526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.14230 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|